A Clinical Study of YK-1169 Versus Ceftazidime-Avibactam in Adults With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

NCT07634198 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

590

Enrollment

INDUSTRY

Sponsor class

Conditions

Hospital-acquired Bacterial Pneumonia (HABP)
Ventilator-associated Bacterial Pneumonia (VABP)

Interventions

DRUG: YK-1169
DRUG: Ceftazidime-avibactam Injection

Sponsor

Nanjing Yoko Biomedical Co., Ltd.